The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Pliant Therapeutics Inc shares valued at $142,408 were sold by Lefebvre Eric on Jul 10 ’24. At $11.56 per share, Lefebvre Eric sold 12,319 shares. The insider’s holdings dropped to 213,052 shares worth approximately $2.74 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Hull Hans sold 9,900 shares, netting a total of over 114,444 in proceeds. Following the sale of shares at $11.56 each, the insider now holds 227,494 shares.
Before that, Cummings Keith Lamont had sold 10,911 shares from its account. In a trade valued at $126,131, the Chief Financial Officer traded Pliant Therapeutics Inc shares for $11.56 each. Upon closing the transaction, the insider’s holdings decreased to 10,911 shares, worth approximately $3.63 million.
Analysts at Wells Fargo started covering the stock with ‘”an Overweight”‘ outlook in a report released in early December. As of May 18, 2023, Canaccord Genuity has initiated its “Buy” rating for PLRX. Earlier on April 13, 2023, Robert W. Baird initiated its rating. Their recommendation was “an Outperform” for PLRX stock.
Analyzing PLRX Stock Performance
Over the course of the year, Pliant Therapeutics Inc shares have dropped approximately -29.04%. Shares of the company reached a 52-week high of $19.62 on 01/08/24 and a 52-week low of $10.22 on 10/02/24. A 50-day SMA is recorded $13.09, while a 200-day SMA reached $13.38. Nevertheless, trading volume fell to 0.69 million shares from 0.57 million shares the previous day.
Support And Resistance Levels for Pliant Therapeutics Inc (PLRX)
According to the 24-hour chart, there is a support level at 12.49, which, if violated, would cause prices to drop to 12.14. In the upper region, resistance lies at 13.23. The next price resistance is at 13.62. RSI (Relative Strength Index) is 42.82 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.02, which suggests the price will decrease in the coming days. Percent R is at 74.88%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
